Logotype for Altamira Therapeutics Ltd

Altamira Therapeutics (CYTO) investor relations material

Altamira Therapeutics H1 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Altamira Therapeutics Ltd
H1 2025 earnings summary29 Aug, 2025

Executive summary

  • Strategic shift to focus on RNA delivery, expanding the client base and advancing the xPhore and Cyclophore platforms, with a planned partial spin-off of the Swiss subsidiary ATAG to attract private equity investors.

  • Legacy assets, including nasal sprays for allergy and vertigo, are being managed for monetization and value appreciation, with continued development of Bentrio and AM-125.

  • Progress in transitioning manufacturing and regulatory status for legacy products, and expansion of intellectual property protection, including a new patent for AM-125 in Japan.

Financial highlights

  • Total operating expenses decreased 32.9% year-over-year to $2.6M, driven by lower G&A and R&D costs.

  • Net loss reduced by 64.6% to $1.5M, mainly due to $1.7M finance income from currency appreciation and lower finance expenses.

  • Cash used in operations fell 56.8% to $1.4M; cash and equivalents at $4,000 as of June 30, 2025, down from $1.0M at year-end 2024.

  • Shareholders' equity at $4.1M as of June 30, 2025, down from $6.6M at year-end 2024.

  • Financing activities provided $400,000 in H1 2025, compared to $2.5M in H1 2024.

Outlook and guidance

  • Operating expenses expected to decrease further after ATAG spin-off.

  • Funding to come from cash, sale of ATAG shares, monetization of legacy assets, and service provision.

  • Financial guidance will be updated upon material developments, especially regarding the ATAG spin-off.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Altamira Therapeutics earnings date

Logotype for Altamira Therapeutics Ltd
H2 202529 Apr, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Altamira Therapeutics earnings date

Logotype for Altamira Therapeutics Ltd
H2 202529 Apr, 2026

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Altamira Therapeutics Ltd is a Switzerland-based biopharmaceutical company focused on developing and commercializing therapies for ear, nose, and throat (ENT) and central nervous system (CNS) disorders. The company's pipeline includes RNA-based therapeutics, as well as treatments for inner ear conditions such as tinnitus and vertigo. Altamira Therapeutics applies its proprietary delivery platforms to target therapeutic molecules effectively, aiming to address unmet medical needs across its key treatment areas. The company is headquartered in Hamilton, Bermuda, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage